Moderna sales beat expectations as growth expands beyond
Moderna's first-quarter sales beat expectations, driven by growth outside the United States, though exact figures and quarter relationships remain unclear in —
Moderna FDA vaccine restrictions Lead to Shares Drop in
The Moderna FDA vaccine restrictions outlined by the FDA are expected to impact Moderna's vaccine approval process and market strategy amid ongoing regulatory